Drawing for KEEPWELL

USPTO serial 98344153

KEEPWELL

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ABID, NABEELA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with KEEPWELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Felicia J. Boyd

Felicia J. Boyd Norton Rose Fulbright US LLP60 South Sixth Street, Suite 3100Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical cost management services; medical cost management; medical cost management in the field of pharmaceuticals; business data analysis and reporting services in the fields of healthcare, pharmaceuticals, and consumer behavior, all for business purposes; providing information in the fields of business management of prescription drug savings, and business management of reduction of out-of-pocket costs and expenses for prescriptions; business management consulting relating to prescription drug costs using analytic and predictive models applied to medical and pharmacy data; consulting services in the field of cost management of drug therapies through medical cost management; consulting services in the field of cost management of drug therapies through medical cost management for site of care and administration of drugs; business administration services, namely, negotiation of business contracts for others with drug manufacturers to enable participant members of pharmacy benefit management clients to obtain discounts on pharmaceuticals; business administration services, namely, negotiation of business contracts for others to enable member populations of pharmacy benefit management clients to obtain discounts and rebates with drug manufacturers; business services provided to the healthcare industry, namely, the collection and reporting of data pertaining to pharmaceuticals for business purposes; specialty retail pharmacy services; providing healthcare operations management services for health plan sponsors, namely, facilitating the administrative coordination of patient care among health plan sponsors, health providers, health facilities, and specialty pharmacies; drug utilization review services; drug formulary business management services; health care utilization and review services; providing business intelligence services in the field of pharmacy benefit managementACTIVE—
036Pharmacy benefit management services; administration of preferred provider plans for a network of pharmacy providers in the field of specialty pharmaceuticalsACTIVE—
044Pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consulting services; health care services, namely, disease management programs; medication therapy management, namely, medication review being medication counseling and medical and pharmaceutical consulting servicesACTIVE—
045Providing health care coordination services being case management services, namely, coordinating medical services for patients to access specialty drug therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 25, 2026EX3GSOU EXTENSION 3 GRANTED—
Jun 24, 2026EXT3SOU EXTENSION 3 FILED—
Jun 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 24, 2025EX2GSOU EXTENSION 2 GRANTED—
Dec 24, 2025EXT2SOU EXTENSION 2 FILED—
Dec 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 25, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 24, 2025EXT1SOU EXTENSION 1 FILED—
Jun 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 24, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 12, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 12, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024DOCKASSIGNED TO EXAMINER—
Apr 23, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 5, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance